Interestingly, treatment of PPAR agonists or PPAR overexpression in the period around experimentally induced ischemia reperfusion or permanent MI shows varying outcomes, with some studies reporting reduced infarct sizes and improved cardiac function, whereas other studies report larger infarct sizes and impaired ventricular function [66]. Here, PPARA is linked to myocardial infarction.